The obesity epidemic demands more insight into genetic predisposition, mechanisms, prevention and therapeutic interventions. Opinions about how to prioritize obesity research in the next decade are many and highly varied. However, in this article I have chosen three areas of focus that arguably should be at the top of the list. These include: (1) the physiologic basis of body weight and body fat regulation; (2) epigenetic mechanisms of energy balance; and (3) the prevention of obesity. The approach needs to be translational and bi-directional with a strong emphasis on basic science including studies of relevant gene expression and animal models of energy balance. Clinical research into mechanisms can challenge the existing paradigms that could direct research back to more basic understanding or to applications to populations at risk. Communication between scientists and physicians at the far end of the spectrum needs new and ongoing emphasis.
Introduction
Obesity is now an epidemic and is the source of many co-morbidities that diminish the quality of life, lead to chronic diseases and limit lifespan. Obesity also presents a tremendous economic burden that includes costs of weight loss, chronic disease management and loss of work productivity. Obesity science has been with us for centuries to millennia. However, within the last 15 years, the increasing prevalence of obesity has been met with the advances in genetics and basic science. Thus, the credibility and financial support for this important area of scientific endeavor has gained momentum.
Like any area of science and medicine, the research agenda is broad and extensive and, like most areas of science and medicine, the breadth of obesity science includes basic, clinical and population science. Within each of these areas, a comprehensive menu of options is available. As we attempt to determine the priorities for obesity research in the next decade, it would be easy to take any number of projects within each of these broad categories and plead need and importance. Examples in each area might be the following: for basic science, understanding the co-activators and co-repressors that control PPAR-dependent adipocyte differentiation in white and brown adipose tissue, respectively. For clinical science, an important focus could be dissecting the genetic mechanisms for b cell failure that leads to the development of type 2 diabetes in the metabolic setting of obesity, expanded waist circumference and insulin resistance. For population science, the direction could be determining the waist circumference for different populations that contribute to an excess risk of type 2 diabetes and cardiovascular disease. However, my choice is not to provide an exhaustive list of potentially important areas of research focus, any and/or all of which could of course be successfully defended, but to turn our attention to three more comprehensive areas where additional understanding would have far-reaching consequences and applications.
The three areas I believe that should be the focus for obesity research in the next decade are: (1) The physiologic basis of body weight regulation; (2) Epigenetics; and (3) The prevention of obesity (Table 1) . These areas in their own right are all substantial avenues of investigative pursuit, however, increasing our understanding here will foster new approaches that may reduce the burden of overweight and obesity in populations and provide new insights into drug therapy for those already in need of therapeutic intervention.
Fat mass regulation
The physiologic basis of weight regulation remains unclear. For years, it has been assumed that regulatory processes match energy intake with energy requirements to maintain a stable body mass and adiposity. In general, the conservation of energy balance for man and adult mammals reflects a complex interplay between energy intake, energy expenditure and storage. The storage of protein is extensive and called upon when carbohydrate stores are limited and/or when insulin is deficient. 1 The storage of carbohydrate is limited and quickly exhausted when energy intake is absent. 2 But fat mass is extensive and capable of sustaining life for weeks to months to years in the severely obese in the absence of food intake. 3 This has led to the thrifty gene hypothesis, 4 a concept not accepted by all. 5 The regulation of weight could be the defense of protein, carbohydrate and/or fat. I believe the evidence strongly supports that adipose tissue mass is defended. This is based in part on the importance of fat mass to reproduction in the female. Menarche, ovulatory cycles, normal menstruation and ultimately lactation are dependent on a threshold quantity of adipose tissue. 6 Although leptin deficiency is associated with delayed maturation of the hypothalamic pituitary ovarian axis, leptin appears to play a permissive rather critical role in initiating puberty. 7 The linkage between body fat and the reproductive axis in girls may have developed in mammals as a mechanism for ensuring that pregnancy will not occur unless there are adequate fat stores to sustain both the mother and the growing fetus and to nurse the infant at birth. 8 Of note, the obesity epidemic in children may provide at least a partial explanation as to why the age of menarche continues to decrease. 9 In 1953, Kennedy observed that young rats adjusted their energy intake so precisely to their energy needs that fat stores remained almost constant. 10 Because damage to the hypothalamus allowed energy intake to increase so that obesity developed, Kennedy would go on to propose the lipostatic model. According to this model, there exists somewhere within the hypothalamus a 'lipostat' that senses fat mass that responds to changes in a circulating factor(s) that communicates information about changes in fat mass so that changes in energy intake and/or energy expenditure can maintain homeostatic control of overall energy balance. Non-lipostatic models point to a communication between organs other than adipose tissue and central regulatory centers that sense changes in the periphery. 11 If as postulated
fat mass is what is regulated, leptin may be the adipose tissue-derived signal that communicates information about changes in fat mass to the brain. Yet, leptin fails to vary with meal intake, falls substantially after several days of fasting and elevations in plasma leptin levels rather than decreases in obesity were not expected. 12 Additional lines of evidence strongly suggest that fat mass is regulated. The ability of leptin to reduce the hyperphagia seen in patients with leptin deficiency and lipodystrophy indicates that reductions in circulating leptin do lead to increases in energy intake. 13 The second is the recidivism of obesity after successful weight reduction. Following weight reduction, most dieters regain about one-third of the weight lost during the next year and are typically back to baseline in 3-5 years. 14 Of interest, leptin injections following weight loss can effectively modify energy expenditure, skeletalmuscle work efficiency, sympathetic nervous system tone and circulating concentrations of thyroxine and triiodothyronine to levels present prior to weight loss. 15 Alternatively, after months of voluntary forced overfeeding, the weight gain returns to baseline within months of the period of overfeeding. 16 The regulation of fat mass has been described as 'set' somewhere centrally in the brain, however, the recent impact of the environment on the incidence of overweight and obesity would indicate that such a setpoint is not simply genetically determined in an individual. Thus, the regulation of body fat appears to be acquired and supports the concept of a 'settling' point rather than a setpoint. Through such a mechanism, the genetic predisposition to obesity can be biologically defended. Subsequent to weight reduction and maintenance of the reduced obese weight, multiple biologic adaptations occur that work together to restore the depleted fat mass (Figure 1) . 17 With reductions in adipose tissue mass, leptin levels decrease. 18 Combined with increases in ghrelin 19 and reductions in GLP-1, 20 reduced obesity results in signals to the brain that increase the energy intake (increased appetite and preference for energy dense foods). 21, 22 With maintenance of the reduced-obese state, the increase in insulin sensitivity is manifested by decreases in adipose tissue lipolysis of stored triglyceride stores (kFFA), increases in insulin-mediated glucose uptake in adipose tissue and skeletal muscle and reductions in hepatic glucose production. 23, 24 In muscle, increases in insulin-mediated glucose uptake results in enhanced glycogen deposition and increases in glucose oxidation. The delivery of fatty acids to skeletal muscle is a result of not only decreases in FFA from adipose tissue, but reductions in VLDL synthesis/secretion by the liver 25 and reduced uptake from TG-rich lipoproteins secondary to relative decreases in the skeletal muscle lipoprotein lipase. 26 Increases in insulin action in adipose tissue also result in increases in adipose tissue lipoprotein lipase . 27 Overall, these results lead to a partitioning of excess energy to adipose tissue storage with relative decreases in fatty acid oxidation by the skeletal muscle (mrespiratory quotient). 28, 29 By maintaining close surveillance of energy intake and expenditure, these changes can be overcome and weight loss sustained.
It remains unclear whether adipose tissue alone or other organs contribute to the feedback regulation of fat mass. The research of the next decade should focus on creative ways to 
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Fat mass Regulation Defense Epigenetics Prevention of excess weight gain examine this question in genetically modified animals and extend these findings to studies in humans. The roles of adipose tissue, adrenal and gonadal steroids, liver, pancreas, the GI tract and skeletal muscle and the peripheral and central nervous systems all need consideration. Potential pathways of feedback regulation have been suggested by Sandoval et al. 30 ( Figure 2 ). These investigations should include insights into mechanisms of body fat defense in the very lean and very obese with perturbations implemented before and after modifications in the energy balance. Continued pursuit of the genetics of populations wherein obesity is rare or epidemic will also be informative. Genes that relate to energy balance would be the place to start, however, in the age of genomic profiling, novel genes will almost certainly be uncovered.
The results of these pursuits will relate to new drug development. More insights into existing or new pathways of body fat defense will enhance our understanding about how to fool Mother Nature. As new compounds become available, it will be important to discern whether the modification of one pathway of energy balance will be additive to the effects of modifying an alternative pathway. At present, the lack of an additive effect of orlistat þ sibutramine 31 indicates the challenge before the pharmaceutical industry and prescribing providers. Additional focus should be applied to those who respond vs those who do not respond to a specific pharmaceutical or even lifestyle perturbation. For instance, in my experience, unless food intake is hunger-driven, patients do not respond to appetite suppressants (unpublished observation). Moreover, the ability of drugs to contribute to the maintenance of the reduced obese state is an area ripe for mechanistic insights. Overall, the defense of body fat is central to obesity science.
Epigenetics
Epigenetics is defined as the changes in gene function that do not relate to changes in DNA sequence. The concept of epigenetics is complex and relates to cells and tissues, and varies over a lifetime in a setting in which the DNA sequence remains unaltered. A number of epigenetic modifications have been identified and include DNA methylation, histone modifications, occupancy of chromatin factors and changes in chromatin structure. The impact of epigenetic changes on gene expression is conceptualized by Feinberg ( Figure 3 ). 32 Epigenetics is an essential part of cell and tissue differentiation during embryogenesis and subsequent growth and development. Moreover, the development of an agingrelated disease can relate to epigenetic changes in gene expression, that is, hypomethylation and colon cancer. 33 Whether or not the environmental influence on gene expression occurs in utero, during early childhood, and/or throughout the process of aging, the likelihood of such an impact on obesity and related co-morbidities is much in need of further investigation. There is no doubt that obesity has a genetic basis, 34 but yet is very much influenced by the environment around us. This concept is conceptualized in Figure 4 . 35 In addition, there is a recent report of genomic imprinting that may be playing a role in common obesity at three different genomic loci. 36 The maternal malnutrition during early gestation experienced by Dutch mothers during World War II was associated with higher BMI and waist circumference in 50-year-old women but not in men. 37 More recent studies in humans indicate that prenatal nutrient deprivation followed by rapid infant growth results in obesity in the offspring. 38 Moreover in rodents, the offspring of protein restricted dams during pregnancy are obese in adulthood. 39, 40 Potential mechanisms for the epigenetics of obesity resulting from modifications of nutrients during development include altered energy intake, energy expenditure and/or adipose tissue development and metabolism. 41 On examination of the impact of signals that could mediate epigenetic effects, leptin may be important. When leptin was administered after birth to rats exposed to prenatal nutrient restriction, a reversal of hyperphagia and obesity was seen in adult life. 42 During development, leptin has also been shown to enhance the outgrowth of neurons from the arcuate nucleus to the paraventricular nucleus in the neonatal hypothalamus. 43 Examples of epigenetic programming could also influence obesity-related co-morbidities. Again, in the setting of maternal low protein intake, the administration of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists during growth and development prevented the development of hypertension. In rats, Bogdarino et al. 44 have recently demonstrated that the expression of the AT(1b) angiotensin receptor gene in the adrenal gland is upregulated early in life. Concomitantly, the proximal promoter of the AT(1b) gene in the adrenal was found to be hypomethylated, an effect highly related to promoter activity. The authors went on to point out that their data suggest a link between fetal insults to epigenetic modification of genes and the resultant alteration of gene expression in adult life. In their model, the co-morbidity of hypertension was the specific outcome. The importance of epigenetic change to the risk for human obesity and related co-morbidities has recently been reviewed by Walley et al. 45 The impact of the obesity on gene expression and the co-morbidities is nicely summarized in Figure 5 . Although at present, convincing evidence that epigenetic modification of gene expression predicts the complications of obesity is lacking, the pursuit of such mechanisms is important, timely, and appropriate for emphasis during the next decade.
Prevention
Because obesity is associated with a number of co-morbidities including hypertension, glucose intolerance, dyslipidemia, obstructive sleep apnea, coronary heart disease, congestive heart failure, deep venous thrombosis and pulmonary thromboembolic disease, cancer, osteoarthritis, gall bladder, hepatic steatosis, and polycystic ovarian disease, 17 one option for an obesity research focus could be to concentrate on a more effective diagnostic screening and treatment of these medical complications with the hope of extending longevity. Specifically for coronary heart disease, approximately half of the decline in US deaths from 1980 to 2000 because of coronary heart disease may have been attributable to reductions in major risk factors and approximately half to evidence-based medical therapies, however, this benefit was in part offset by increases in the BMI and the prevalence of diabetes, which accounted for an 8-10% increased number of deaths. 46 The aggregate cost of overweight and obesity in the US for 1998 (excluding institutionalized populations) was $51 000 000 000. 47 Of course, if weight gain were prevented, the costs of treating obesity and its complications would be substantially reduced. In 2007, the cost of weight reduction among America's 72 000 000 dieters alone was estimated to be a $55 billion US industry 48 (http://www.prwebdirect.com/ releases/2007/4/prweb520127.php). As aforementioned, this expenditure is largely wasted with only a small percentage of dieters successful in losing more than 5% of their weight and sustaining the weight loss for 5 years or longer. Moreover, the benefit of medically induced weight loss on major CVD events, cancer and/or all-cause mortality has yet to be demonstrated. The prevention of obesity is a monumental task and extends all the way from maternal nutrition and weight change to the role of government ( Table 2) .
The evidence for the effect of protein and energy malnutrition on obesity in the offspring has been already mentioned. 49, 50 The prevention of excessive weight gain during pregnancy may be another area in which to focus, that is, with women being informed about appropriate Figure 2 The postential overlapping mechanisms involved in central nervous system (CNS) regulation of energy balance and glucose homeostasis. After a meal is ingested, nutrients stimulate the release of satiety signals from the gut and either enter the circulation where they can directly stimulate the CNS or are stored. The stored form of fuels, in particular adipose tissue, directly correlates with leptin and insulin levels. All these signals converge on the CNS, specifically the hypothalamus, to inform the brain of fuel availability. Subsequently, the CNS initiates and coordinates changes in energy and glucose homeostasis in peripheral tissues such as the pancreas, the liver, adipose tissue and skeletal muscle. Although the mechanism remains to be firmly established, it may involve the actions of a long-chain fatty acidFCoA potassium-dependent ATP channels (K ATP ), AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR weight gain and specific weight-gain goals. 51 When glucose intolerance is present in pregnancy, data from a multiethnic US population suggest that more hyperglycemia during pregnancy is associated with an increased risk of childhood obesity. 52 Still needed are data to demonstrate that controlling glycemia in women with gestational diabetes reduces the incidence of childhood obesity. This has been well proven for women with diabetes.
53
Using cross-sectional data from a sample of 2-to 5-year-old children (n ¼ 1521) in the National Health and Examination Survey 1999-2002, Mexican American children had significantly better diet quality than non-Hispanic white children especially in the low income group, and childhood obesity prevalence decreased significantly with increasing diet quality. 54 The dilemma is how to improve the diet of preschoolers and adequately deal with the related ethnic and socioeconomic issues. For school-aged children, the prevention of obesity is even more uncertain. Kropski et al.
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recently reported a meta-analysis from which they concluded that 'our ability to draw strong conclusions as to the efficacy of school-based obesity prevention programs is limited by the small number of published studies and by methodological concerns'. Qualitative analysis suggests programs grounded in social learning may be more appropriate for girls, while structural and environmental interventions enabling physical activity may be more effective for boys. The adolescent period is an additional challenge. Figure 3 Life cycle of the epigenome unlike the DNA sequence, the epigenetic code changes during one's lifetime in ways specific to a given cell type. Shown here are a sperm, which is highly methylated, and an egg, which is not. After fertilization, there is a wave of demethylation that spares imprinted marks. Tissue-specific methylation patterns emerge during later embryonic development. Age-related hypermethylation or hypomethylation could theoretically impair or enhance normal gene responsiveness to environmental signals. Just recently, Barlow 56 has reported the recommendations of the Expert Committee regarding the prevention, assessment and treatment of child and adolescent overweight and obesity in Pediatrics. Without being trite, this report states that 'because effective strategies remain poorly defined, the writing groups used both available evidence and expert opinion to develop the recommendations'. Stated within the report is that 'providers can provide obesity prevention messages for most children and suggest weight control interventions for those with excess weight. The writing groups also recommend changing office systems so that they support efforts to address the problem. BMI should be calculated and plotted at least annually, and the classification should be integrated with other information such as growth pattern, familial obesity and medical risks to assess the child's obesity risk. For prevention, the recommendations include both specific eating and physical activity behaviors, which are likely to promote maintenance of healthy weight, but also the use of patient-centered counseling techniques such as motivational interviewing, which helps families identify their own motivation for making change. These recommendations recognize the importance of social and environmental change to reduce the obesity epidemic but also identify ways healthcare providers and health care systems can be part of broader efforts.' Clearly little is known at present as to the effectiveness of such strategies. The early adult years are a time of maximum weight gain for adults in the United States. 57, 58 And for US immigrants, the number of years of residence in the US is associated with a higher BMI beginning after 10 years from immigration with the prevalence of obesity approaching that of US-born adults by 15 years. 59 The explanation for this increasing prevalence must relate to an imbalance of energy intake with energy expenditure, but the science of prevention is far from worked out. Typically after mid-life, body weight and BMI reach a plateau; however, in the absence of moderately extensive exercise training changes in body composition then occur. 60 And although sarcopenia contributes to physical disabilities and aging-related morbidities, 61 the health consequences of obesity on longevity remain uncertain. 62 On whom should be placed the responsibility for obesity prevention? Clearly each and every mentally competent individual has a role. During pregnancy and for the baby, it is Figure 5 Examples of clinically relevant biomarkers for assessing the development of obesity and its sequelae. The dotted line represents the division between clinical health and disease. Adapted from Walley et al. 45 by permission of Oxford University Press. ACE, angiotensin 1-converting enzyme (peptidyl-dipeptidase A)1; AGEs, advanced glycation endproducts; AKRIB10, aldo-keto reductase family 1, member B10 (aldose reductase); AMACR, a-methylacly-CoA racemase; CART, cocaine-and amphetamine-regulated transcript; COL1A1, collagen type 1 a; CR1, cannabinoid receptor 1; ENPP1, ectonucleotide pyrophosphatase/ phosphodiesterase 1; MC4R, melanocortin 4 receptor; MTHFR, 5,10-methylenetetrahydrofolate reductase (NADPH); NR, nuclear receptor; POMC, proopiomelanocortin; PPARG, peroxisome proliferator-activated receptor g; TCF7L2, transcription factor 7-like 2 (T-cell specific, HMG-box); TGFB1, transforming growth factor, b 1; VDR, vitamin D (1,25-dihydroxyvitamin D3) receptor. (Table 3 ). An example for the Industry Pillar is the arrangements made by the Alliance with the American Beverage Association and Snack Food Industries for the provision of healthier options for school age children in schools. The School Pillar has been assisted by a substantial grant from the Robert Wood Johnson Foundation to modify school lunches and physical activity programs particularly in schools in which minority populations and lower socioeconomic status prevail. The Kids Pillar is being supported by the Nickelodeon Company where abundant programming and free advertising endorse a healthy lifestyle directly to children. And finally, the Health Care Pillar is working with Third Party Payers to reimburse efforts in providers' offices for obesity prevention and treatment. Although the value of any or all of these types of interventions remains unclear, the effort does reflect the importance of a comprehensive approach to modify the lives of the involved and the surrounding environment in an attempt to favorably modify weight gain at a very young age. The value of this type of intervention will hopefully be seen in the US and ultimately in other parts of the developed and developing world. Yet, the biggest barrier remainsFhow do we modify human behavior? That's where much of this research on prevention should be directed. Table 3 Alliance for a healthier generation Goal: To stop the increasing prevalence of childhood obesity in the United States by 2010 and reduce the prevalence of childhood obesity by 10% by 2015.
Genes

Industry
Work with restaurants, foods and beverages manufacturers and distributors and the fitness industry to improve and school economics.
Creating a program to effect consumer choice and available meals at restaurants Develop healthier options & favorable economics for schools.
Schools
Develop innovative approaches to encourage more healthy food options and increase physical activity during and after school.
Create a recognition program that rewards schools for creating and sustaining healthy environments Collaborate with school, parent, community groups Kids Create a 'for kids, by kids' movement to mobilize kids and communities to take charge of their own health. Develop tools for families, schools and healthcare providers Partner with media to encourage healthy lifestyles in programs and to support a PSA campaign to support the movement.
Healthcare
Work with professional associations and other healthcare groups to create tools and CMEs that help providers better recognize, prevent and treat obesity in children. Doing research on barriers to treating and preventing obesity in medical offices
